Our Transactions
Leadership across the largest and most complex situations
Lead Financial Advisor
on its pending €8.0 billion
acquisition of
from Vodafone Group
2024
Exclusive Financial Advisor
on its pending ~$2.3 billion
acquisition of
2024
Independent Financial Advisor
on its pending acquisition of three fill-finish sites for an upfront payment of $11 billion from Novo Holdings following its $16.5 billion acquisition of Catalent
2024
Exclusive Financial Advisor
on its pending ~$35 billion
acquisition of
2024
Exclusive Financial Advisor
on its pending ~$12.6 billion
sale to
2024
Lead Financial Advisor
on its pending $11.5 billion
all-stock merger with
2024
Lead Financial Advisor
on its pending ~$13.4 billion
sale to
2023
Financial Advisor
on its pending ~$14.9 billion
sale to
2023
Financial Advisor
on its pending $60 billion
all-stock acquisition of
2023
Financial Advisor
on its up to $5.8 billion
acquisition of
2023
Financial Advisor
on its pending ~$20 billion
merger with
2023
Lead Left Bookrunner
$300 million
Follow-on Offering
2023
Exclusive Financial Advisor
on its chapter 11 restructuring of ~$1.9 billion of debt and $125 million DIP ABL financing
2023
Active Bookrunner
$1.1 billion IPO & $1.6 billion
Follow-on Offering
2023
Exclusive Financial Advisor
on its pre-packaged chapter 11 restructuring of ~$3.6 billion of debt and preferred equity
2023
Lead Financial Advisor
on its ~$36 billion
spin-off of
2021
Anouncement Date1
Status
Transaction
Value (M)
January 6, 2022
Closed
Acted as an Active Bookrunner on Amylyx Pharmaceuticals’ initial public offering
~$216
January 6, 2022
Closed
Advised Sygnum Bank AG on its Series B private fund raise
$90
January 6, 2022
Closed
Advised Vocera Communications, Inc. on its sale to Stryker Corporation
~$3,100
January 5, 2022
Closed
Advised ABC Technologies Holdings Inc. on its acquisition of dlhBowles
~$255
January 5, 2022
Closed
Advised Clearlake Capital on the recapitalization of symplr via a new Clearlake-managed dedicated single-asset fund
~$1,600
January 4, 2022
Closed
Advised S&P Global on its acquisition of The Climate Service, Inc.
N/A
January 4, 2022
Closed
Acted as an Active Bookrunner on Intra-Cellular Therapies' follow-on offering
$460
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.
« Previous 1 … 17 18 19